Compare
Abundia Global Impact Group, Inc. vs Arcadia Biosciences, Inc. vs Prairie Operating Co. vs Tamboran Resources Corp
| Latest fiscal year | Abundia Global Impact Group, Inc. AGIG | Arcadia Biosciences, Inc. RKDA | Prairie Operating Co. PROP | Tamboran Resources Corp TBN |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-06-30 |
| Revenue | $410.6K | $4.86M | $241.65M | $0 |
| Revenue growth (YoY) | -26.7% | -3.7% | n/m | n/a |
| Gross margin | n/a | 36.2% (computed) | n/a | n/a |
| Operating margin | n/m | -51.5% | 27.1% | n/a |
| Net margin | n/m | -48.1% | 13.3% | n/a |
| Net income | -$29.45M | -$2.34M | $32.05M | -$36.90M |
| EPS (Diluted) | -$0.90 | -$1.71 | -$1.35 | -$2.52 |
| Operating cash flow | -$8.05M | -$4.74M | $153.90M | -$29.64M |
| Free cash flow | -$16.71M | -$4.74M | n/a | n/a |
| Cash & equivalents | $4.62M | $259.0K | $20.0K | $39.44M |
| Total assets | $31.86M | $6.55M | $944.55M | $446.46M |
| Total liabilities | $12.84M | $2.41M | $678.24M | $57.01M |
| Shareholders' equity | $19.01M | $4.14M | $130.16M | $287.72M |
| Return on year-end equity | -154.9% | -56.5% | 24.6% | -12.8% |
| Shares outstanding | 36.92M | 1.37M | 62.50M | 16.72M |
Revenue, most recent five fiscal years
| Fiscal year | Abundia Global Impact Group, Inc. | Arcadia Biosciences, Inc. | Prairie Operating Co. | Tamboran Resources Corp |
|---|---|---|---|---|
| Latest | $410.6K Ended 2025-12-31 | $4.86M Ended 2025-12-31 | $241.65M Ended 2025-12-31 | $0 Ended 2025-06-30 |
| 1 year earlier | $560.2K Ended 2024-12-31 | $5.04M Ended 2024-12-31 | $7.94M Ended 2024-12-31 | $0 Ended 2024-06-30 |
| 2 years earlier | $794.0K Ended 2023-12-31 | $4.45M Ended 2023-12-31 | $1.55M Ended 2023-12-31 | n/a |
| 3 years earlier | $1.64M Ended 2022-12-31 | $7.42M Ended 2022-12-31 | $517.6K Ended 2022-12-31 | n/a |
| 4 years earlier | $1.33M Ended 2021-12-31 | $6.78M Ended 2021-12-31 | $369.8K Ended 2021-12-31 | n/a |